Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2017 - Research and Markets

Research and Markets
Posted on: 18 Dec 17

The "Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Chronic Obstructive Pulmonary Disease (COPD) (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 6, 1, 13, 37, 23, 84, 23 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 9 and 1 molecules, respectively.

Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Chronic Obstructive Pulmonary Disease (COPD) - Overview
  3. Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics Development
  4. Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics Assessment
  5. Chronic Obstructive Pulmonary Disease (COPD) - Companies Involved in Therapeutics Development
  6. Chronic Obstructive Pulmonary Disease (COPD) - Drug Profiles
  7. Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects
  8. Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products
  9. Chronic Obstructive Pulmonary Disease (COPD) - Product Development Milestones
  10. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/hdl4n5/chronic?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20171218005995/en/

Business Wire
www.businesswire.com

Last updated on: 18/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.